Pressmeddelanden, rapporter och bolagsmeddelande för Optomed Oyj

The Annual General Meeting (AGM) of Optomed Plc, held on 10 May 2024, adopted the financial statements for 2023 and confirmed the Board of Directors’ decision not to pay a dividend for that year. The AGM also re-elected the six members of the Board of Directors, confirmed the annual Board remuneration, and re-elected KPMG Oy Ab as the company's auditor. Changes were made to the terms of the Stock Option Plans, extending the subscription periods for shares under each plan to end on 31 December 2027. The AGM also authorized the Board to repurchase Optomed’s own shares and to issue shares and other special rights. At a subsequent meeting, the Board elected Petri Salonen as its Chairman.

Optomed Plc has announced its Annual General Meeting (AGM) to be held on 10 May 2024. Shareholders registered by 26 April 2024 are eligible to attend the meeting. The AGM will discuss matters including the adoption of financial statements, the use of profit shown on the balance sheet, the discharge of the board of directors and CEO from liability, and the remuneration policy for governing bodies. The board proposes no dividend to be paid for the financial period of 1 January – 31 December 2023 due to a loss in that period. The board also proposes the adoption of the remuneration report and policy for governing bodies, with no material changes suggested. The AGM will also consider the re-election of current board members, the remuneration of the auditor, and amendments to the terms of stock option plans. Shareholders can vote in advance, with instructions provided in the notice.